Log In
Print this Print this

quilizumab (MEMP1972A) (RG7449)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHumanized mAb against M1 prime segment of membrane IgE
Molecular Target Immunoglobulin E (IgE)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat allergic asthma; Treat asthma
Regulatory Designation
Partner Genentech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today